Skip to main content
    F

    Fulcrum Therapeutics Inc (FULC)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.75
    +0.04 (+1.08%)

    Market Cap: $283.38M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    Fulcrum Therapeutics Inc (FULC) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Fulcrum Therapeutics (FULC) has a latest price of $3.75 on Nov 17, 2026, 76.2% below its 52-week high of $15.74. Its price fell 56.6% over the past 12 months. The month-end price fell 83.2% over the 5 years through Oct 2026, a compound annual decline of 30.0%.

    Price Chart

    From Jul 2019 to Oct 2026, its highest month-end close was $29.70 in Aug 2021 and its lowest $2.50 in Apr 2023, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart FULC with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for FULC.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price fell 4.1%, and over 6 months it fell 36.5%. The month-end price rose 1.9% over the 3 years through Oct 2026, a compound annual rate of 0.6%.

    PeriodChange
    1 month+1.4%
    3 months-4.1%
    6 months-36.5%
    12 months-56.6%
    12 months, with dividends-56.6%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+1.9%+0.6%
    5 years-83.2%-30.0%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2025, when the price rose 140.6%, and its weakest was 2022, when it fell 58.8%.

    YearCloseChange
    2026 through Oct 2026$3.71-67.2%
    2025$11.31+140.6%
    2024$4.70-30.4%
    2023$6.75-7.3%
    2022$7.28-58.8%
    2021$17.69+51.1%
    2020$11.71-29.6%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 0.5% above its 50-day average of $3.73 and 31.1% below its 200-day average of $5.45.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$3.75
    52-week high$15.74-76.2%
    52-week low$2.83+32.5%
    50-day average$3.73+0.5%
    200-day average$5.45-31.1%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 79.1%.

    MeasureValue
    1-year beta0.53
    Largest fall, 1 year-78.5%
    Largest fall, 3 years-79.1%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About FULC

    What is FULC's 1-year price change?

    Fulcrum Therapeutics's price fell 56.6% over the past 12 months. With dividends included, the 12-month total return was -56.6%.

    What is FULC's 5-year price change?

    Fulcrum Therapeutics's month-end price fell 83.2% over the 5 years through Oct 2026, a compound annual decline of 30.0%. These figures leave out dividends.

    What is FULC's 52-week high and low?

    Fulcrum Therapeutics's 52-week high is $15.74 and its 52-week low is $2.83. Its latest price of $3.75 on Nov 17, 2026 is 76.2% below the high.

    What is FULC's beta?

    Fulcrum Therapeutics's 1-year beta against the S&P 500 is 0.53, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 78.5%.

    Is the FULC chart free?

    Yes. Advanced Charting for FULC is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.